These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 1759839)

  • 21. Comparison of antimicrobial susceptibilities of Corynebacterium species by broth microdilution and disk diffusion methods.
    Weiss K; Laverdière M; Rivest R
    Antimicrob Agents Chemother; 1996 Apr; 40(4):930-3. PubMed ID: 8849254
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro activity of linezolid and 12 other antimicrobials against coryneform bacteria.
    Gómez-Garcés JL; Alos JI; Tamayo J
    Int J Antimicrob Agents; 2007 Jun; 29(6):688-92. PubMed ID: 17475450
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [In vitro activity of twenty antibiotics against Rhodococcus equi].
    Clavé D; Archambaud M; Rouquet RM; Massip P; Moatti N
    Pathol Biol (Paris); 1991 May; 39(5):424-8. PubMed ID: 1652730
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An overview of antimicrobial therapy.
    Liu C
    Compr Ther; 1992 Nov; 18(11):35-42. PubMed ID: 1478057
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New antibiotics: carbapenems, monobactams and quinolones.
    Amin NM
    Am Fam Physician; 1988 Oct; 38(4):125-34. PubMed ID: 3051970
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro activity of newer antibiotics against Corynebacterium jeikeium, Corynebacterium amycolatum and Corynebacterium urealyticum.
    Sánchez Hernández J; Mora Peris B; Yagüe Guirao G; Gutiérrez Zufiaurre N; Muñoz Bellido JL; Segovia Hernández M; García Rodríguez JA
    Int J Antimicrob Agents; 2003 Nov; 22(5):492-6. PubMed ID: 14602367
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro susceptibilities of aerobic and facultative non-spore-forming gram-positive bacilli to HMR 3647 (RU 66647) and 14 other antimicrobials.
    Soriano F; Fernández-Roblas R; Calvo R; García-Calvo G
    Antimicrob Agents Chemother; 1998 May; 42(5):1028-33. PubMed ID: 9593121
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Corynebacterium equi: in vitro susceptibility to twenty-six antimicrobial agents.
    Woolcock JB; Mutimer MD
    Antimicrob Agents Chemother; 1980 Dec; 18(6):976-7. PubMed ID: 7235683
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative in vitro activity of the new cyclic lipopeptide LY146032 against Corynebacterium species.
    Spitzer PG; Eliopoulos GM; Karchmer AW; Moellering RC
    Eur J Clin Microbiol; 1987 Apr; 6(2):183-5. PubMed ID: 3036499
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antibiotic susceptibility profile of Xanthomonas maltophilia. In vitro activity of beta-lactam/beta-lactamase inhibitor combinations.
    García-Rodríguez JA; García Sánchez JE; García García MI; García Sánchez E; Muñoz Bellido JL
    Diagn Microbiol Infect Dis; 1991; 14(3):239-43. PubMed ID: 1889176
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Urinary Corynebacterium group D2 infections. A hospital epidemic and antibiotic sensitivity].
    Fosse T; Carles D; Laffont C; Lefebvre JC; Bocquet JP
    Pathol Biol (Paris); 1988 Jun; 36(5 Pt 2):742-5. PubMed ID: 3054760
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multidrug-resistant gram-positive pathogens. An update on current microbiological patterns.
    Marchese A; Debbia EA; Bacca D; Balistreri G; Musolino B; Schito GC
    Drugs; 1997; 54 Suppl 6():11-20. PubMed ID: 9474477
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of the in vitro activity of levofloxacin and other antimicrobial agents against vancomycin-susceptible and vancomycin-resistant Enterococcus species.
    Hayden MK; Matushek MG; Trenholme GM
    Diagn Microbiol Infect Dis; 1995 Aug; 22(4):349-52. PubMed ID: 8582142
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of teicoplanin and vancomycin disk susceptibility tests.
    Barry AL; Thornsberry C; Jones RN
    J Clin Microbiol; 1986 Jan; 23(1):100-3. PubMed ID: 2939101
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacodynamics of antimicrobial agents and rationale for their dosing.
    MacGowan AP; Bowker KE
    J Chemother; 1997 May; 9 Suppl 1():64-73. PubMed ID: 9248964
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of infection and colonization caused by methicillin-resistant Staphylococcus aureus.
    Chambers HF
    Infect Control Hosp Epidemiol; 1991 Jan; 12(1):29-35. PubMed ID: 1847961
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gram-positive resistance: challenge for the development of new antibiotics.
    Baquero F
    J Antimicrob Chemother; 1997 May; 39 Suppl A():1-6. PubMed ID: 9511055
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro activity of tigecycline and 10 other antimicrobials against clinical isolates of the genus Corynebacterium.
    Fernandez-Roblas R; Adames H; Martín-de-Hijas NZ; Almeida DG; Gadea I; Esteban J
    Int J Antimicrob Agents; 2009 May; 33(5):453-5. PubMed ID: 19153032
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Multiply resistant Pseudomonas aeruginosa in the pediatric field].
    Tabuki K
    Nihon Rinsho; 1991 Oct; 49(10):2387-92. PubMed ID: 1660948
    [No Abstract]   [Full Text] [Related]  

  • 40. Antimycoplasmal activities of new quinolones, tetracyclines, and macrolides against Mycoplasma pneumoniae.
    Arai S; Gohara Y; Kuwano K; Kawashima T
    Antimicrob Agents Chemother; 1992 Jun; 36(6):1322-4. PubMed ID: 1416832
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.